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Abstract 
Energy dispersive X-ray microanalysis was per-
formed on altogether 42 surgically removed tissue speci-
mens of 32 patients, which were taken either from intact 
thyroid parts or various histopathologically verified 
tumors of the thyroid gland. The tissue specimens were 
processed with the freeze-fracture-freeze-drying tech-
nique and then analyzed in the so-called bulk specimen 
form. The studies were carried out during the years 
1980-81, when intranuclear monovalent ionic composi-
tion was studied in detail. From the retained total ele-
mental peak list, it was possible to calculate retrospec -
tively the relative intranuclear Mg and P contents . The 
data processed by nested (hierarchical) analysis of vari-
ance show that the intranuclear Mg content of the 5 di-
agnostic groups (normal thyroid tissue, thyroiditis, be-
nign adenomas, differentiated carcinomas and undiffer-
entiated thyroid tumors) increases significantly, in par-
allel with the increasing malignancy, but the P content 
remains unchanged. One can conclude that the elevated 
intranuclear Mg content in the tumors of high malig-
nancy may be of diagnostic importance, and a warning 
signal for the therapeutic approaches based on Mg-
supplementations . 
Key Words: Intranuclear Mg content, intranuclear P 
content, thyroid gland, thyroid tumors, X-ray micro-
analysis of bulk specimens. 
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Introduction 
Magnesium (Mg) is a divalent cation of vital impor-
tance. Its ability to influence in vitro protein synthesis 
has been recognized already during the early experi-
ments with ribosomes (Zamecnik, 1960). It has also 
been revealed that Mg is involved in the initiation of 
DNA replication in dividing cells, i.e., its regulatory 
role of growth in normal and cancer cells is obvious 
(Heeley et al . , 1974; Rubin et al. , 1979; Terasaki and 
Rubin, 1985; Walker, 1986; Cameron and Smith, 
1989a,b). 
For obvious methodological reasons, the majority of 
human investigations refer to Mg concentrations in blood 
serum. Attention has recently been paid to the fact that 
no information is available even on the serum Mg levels 
in a great percentage of the patients, since Mg level-
measurements are not part of routine laboratory exami-
nations (Whang and Ryder, 1990). It is also a generally 
accepted view that the connection between magnesium 
and tumorous diseases is very complex: administration 
of Mg is capable of producing anticarcinogenic effects 
in some cases, whereas in other ones, just the opposite 
effect was observed both in vivo and in vitro (Durlach et 
al., 1986). 
Although it would be important to monitor the intra-
cellular Mg contents in various phases of normal and tu-
morous growth, data on this parameter are rather scarce. 
This is due to multiple methodological limitations as 
explained below . 
(1) The atomic absorption spectroscopic techniques 
applicable to blood samples and extracts of tissue homo-
genates (see e.g., Szmeja and Konczewska, 1986) can 
reveal only serum, total tissue or tumor Mg-contents . 
The situation is further complicated by the fact that the 
serum contains usually only about 1-2 % of the total Mg 
content of the organism (Holtmeier, 1988). Therefore, 
we can hardly draw well-founded conclusions regarding 
the role and metabolism of Mg without knowing the in-
tracellular Mg content. The necessity of such knowl-
edge was emphasized by others, too (Elin and Hosseini, 
1985; Dolev et al. , 1988). 
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(2) Although the energy dispersive X-ray microana-
lytic technique available for biological purposes since the 
early seventies, is suitable to reveal the intracellular 
elemental composition, including Mg concentrations (see 
for references: Zs.-Nagy, 1983, 1989; Cameron and 
Smith, 1989b; Zs.-Nagy and Casoli, 1990), it could not 
gain a sufficiently wide application because of the need 
of complicated preparative procedures and expensive 
equipment, as well as well trained persons. Due to this 
situation, the available papers regarding intracellular Mg 
contents in various intermitotic or mitotic cell types 
concern only animal tissues , as listed below: (i) normal 
and cancerous liver cells of rat (Smith et al., 1978; 
Cameron et al. , 1979a); (ii) enterocytes of female C3H 
mice (Cameron et al., 1979b); (iii) skeletal muscle cells 
of normal and cardiomyopathic hamsters (Cameron et 
al., 1990); (iv) normal and tumorous mammary epitheli-
um of mouse and rat (Cameron et al., 1980); and (v) 
normal rat and pig thyroid follicular cells and the colloid 
taken from in vivo glands or kept in culture (Wroblewski 
et al., 1991; Wroblewski, 1994; Wroblewski and 
Wroblewski, 1994). 
The significance of the Mg content of cells was re-
viewed by Cameron and Smith (1989a): they reached the 
conclusion that while the average intracellular Mg con-
tent amounts to 50 ± 3 .1 mmole/kg dry weight in slow-
1 y dividing cell types (hepatocytes, lactating mammary 
epithelium, smooth muscle cells, cardiac myocytes from 
32- or 64-day-old mice , pancreatic acinar cells, bladder 
epithelium and medullary thymocytes , all showing a cell 
turnover time longer than 7 days) , this parameter is 
slightly but significantly higher (63 ± 3 mmole/kg dry 
weight) in rapidly dividing cells (duodenal crypt cells, 
cardiac myocytes from 2- or 4-day-old mice, colon crypt 
cells and cortical thymocytes, all showing a cell turnover 
time shorter than 7 days). 
To the best of our knowledge, no data are available 
comparing the intracellular or intranuclear Mg and P 
contents of the human thyroid tissue and its tumors. 
This fact prompted us to perform a retrospective analysis 
in our earlier human biopsy material , as described in 
this paper . 
During the early eighties, we investigated the 
changes in intracellular monovalent ionic composition in 
thyroid tumors of various levels of malignancy by means 
of the bulk specimen X-ray microanalysis (Lukacs et al. , 
1983; Zs.-Nagy et al., 1983) . That time , however, we 
did not evaluate the X-ray spectra for Mg and P. Since 
the computerized energy-dispersive X-ray microanalysis 
gave us a full list of the elements in the specimen, it was 
possible now to review our previously recorded peak 
lists of the X-ray spectra also for Mg and P. We could 
calculate the relative changes in Mg and P content for 
normal and tumor cells showing different stages of 
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malignancy. On the basis of the results reported in the 
present communication, one can assume that the investi-
gation of intracellular Mg content may be one of the 
subjects of tumor research in the near future. This 
claim is underlined by the fact that in spite of the contra-
dictory judgements and unclear status of the role of Mg 
in tumor cell growth (Durlach et al., 1986), cancer ther-
apy in humans already applies adjuvant treatments based 
on Mg supplementation. 
Materials and Methods 
Our criteria for surgical sampling are dealt with in 
detail in earlier communications (Lukacs et al., 1983; 
Zs.-Nagy et al., 1983). The samples excised in the 
course of surgical intervention can be divided into the 
following five groups. It should be stressed that parallel 
histopathology has confirmed the diagnosis for each 
sample removed. 
(1) Normal thyroid tissue (Group C): these samples 
were taken when, because of the nature of surgical inter-
vention, solitary, so-called cold nodules were removed 
by deep incision into the intact tissue, or the tumor on 
one side had to be removed together with the virtually 
intact contralateral lobe. The intact structure of the 
control tissue specimens was checked in every case by 
histopathological methods and also using the morpholog-
ical picture obtained by scanning electron microscopy. 
We are completely aware of the possibility that the tis-
sue samples used as controls may perhaps be affected in 
some way by the presence of tumors in the given indi-
vidual, even if the microscopical structure proved to be 
intact. Nevertheless , this compromise must be accepted, 
since, for ethical reasons, one cannot obtain entirely 
intact human thyroid tissue for experimental purposes 
from healthy persons . 
(2) Cases of thyroiditis (Group T) which were op-
erated because of suspicion of malignancy, however, 
histopathology could not prove the presence of it later. 
We had only three such cases. 
(3) Benign adenomas (Group A). 
(4) Highly differentiated carcinomas (Group D). In 
this group , follicular and papillary carcinomas , their 
mixtures and one case of medullary carcinoma were 
classified. 
(5) Undifferentiated tumors (Group UD). Ana-
plastic and planocellular carcinomas have been classified 
in this group. In addition, one immunoblastic lymphoma 
was also included. The pronounced proliferativity and 
clinical malignancy of these cases have been proven also 
by the postoperative follow-up. 
X-ray microanalysis 
The detailed description of this method is contained 
in previous communications (Zs.-Nagy et al., 1977, 
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Figure 1. The main trends of changes in the relative P 
and Mg concentrations as well as the P/Mg ratios. P 
and Mg values ± standard error of the mean (S.E.M .) 
are given numerically in Table 4. P/Mg values were 
calculated from the individual averages (Tables 1 and 2) 
and group averages are shown. It is obvious that the 
increase in Mg content with increasing malignancy is the 
main cause of the decrease in the P/Mg ratio. 
1983; Zs.-Nagy, 1983, 1989) , therefore , we summarize 
here only the major steps : (a) The excised piece of the 
specimen , cut to the shape of a piece of match is imme-
diately frozen by immersion into isopentane cooled to its 
freezing point (-165°C) with liquid nitrogen. (b) The 
elongated specimens, while still in the cooled isopentane , 
are broken with scissors in the transversal direction. In 
this way, inner broken surfaces of the specimen are re-
vealed which did not suffer any damage during the exci-
sion . ( c) The broken specimens are frozen-dried until 
complete dryness. (d) The freeze-fractured frozen-dried 
(FFFD) (Zs.-Nagy et al., 1977) tissue specimens are 
fixed to appropriate sample holders then, without any 
further procedure, put into the scanning electron micro-
scope, where X-ray microanalysis is performed at a 10 
kV accelerating voltage in the morphologically well-rec-
ognizable cell nuclei at ~450 cps for 40 seconds. (e) 
The X-ray spectrum obtained is processed by a computer 
program calculating the background intensity (B) (taken 
between 4 and 6 ke V of energy, where no characteristic 
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elemental peaks are present) and the specific elemental 
peak intensity ("P"). The quotient of these parameters, 
the "P/B ratio", is proportional with the relative differ-
ences in concentration according to the mass fraction 
method (Hall et al., 1973; Zs .-Nagy and Casoli, 1990). 
If standards are available, absolute concentrations can be 
calculated. It should be noted, however, that at the time 
of our investigations, we did not use Mg- or P-stand-
ards. Because during the more than 15 years since those 
investigations, spectrometer parameters changed (e.g., 
the so-called "dead silicone layer" of the semiconductor 
detector increased, the Be window had to be renewed), 
Mg and P standard measurements performed now would 
not be quantitatively accurate for the old data. There-
fore , we decided to present our results on Mg and P 
contents only in relative terms. This method is perfectly 
suitable to the actual purpose of our studies. 
The data obtained have been presented first individ-
ually for each diagnostic class (Tables 1 and 2). How-
ever , since there was substantial variation between indi-
vidual means even within the same diagnostic groups, 
the method of nested (hierarchical) analysis of variance 
(Sokal and Rohlf, 1981; Zar, 1984) seemed to be the 
correct method of statistical evaluation , as explained in 
Results. On the basis of the results of the nested anal-
ysis of varian ce (ANOV A) , we have also performed the 
two-tailed Student's t-test for the total pool of measured 
nuclei in each tumor class against the controls . 
Results 
Tables 1 and 2 show the "P/B ratios" of Mg and P 
in the cell nuclei found in the FFFD samples of normal 
thyroid cells of 10 different patients (Group C), com-
pared to those obtained in tissue samples classified as 
thyroiditis (Group T) by the histopathological analysis. 
These data represent quite a homogeneous pool, al-
though some differences can be encountered even within 
the same diagnostic group . 
Tables 1 and 2 present the same parameters found 
in the cell nuclei of thyroid tumors of various levels of 
malignancy, too . The "P/B ratios" are proportional to 
the absolute element contents, and they are directly com-
parable to each other within our experiments, since the 
analytical conditions used were identical for each of 
them. Since, however, other authors used different ana-
lytical conditions , direct comparison of our "P/B" data 
is not possible with the data found by others in animal 
tissues, and cited in the Introduction. 
Since the surface of the FFFD specimen is usually 
not a smooth one, in order to minimize the eventual ana-
1 ytical errors caused by this roughness, we have calcu-
lated the average P/Mg ratios. They are presented 
graphically in Figure 1 for all groups of diagnoses. 
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Table 1. The average peak intensity to background intensity ratio (P/B) of magnesium in the nuclei of intact thyroid, 
thyroiditis, and thyroid tumor cells of various levels of malignancy (n = number of measured cells). 
!dent. Sex P/B ± S.D. ± S.E .M. n PS 
Control thyroid tissue (C) 
1. F 0.0120 0.0173 0.0015 125 
2. F 0.0099 0.0133 0.0017 60 
3. F 0.0076 0.0146 0 .0024 38 
4. F 0.0105 0.0121 0.0022 30 
5. F 0.0056 0.0085 0.0011 60 
6. F 0.0118 0.0123 0.0023 81 
7. F 0.0156 0.0153 0.0024 40 
8. F 0.0137 0.0169 0.0029 33 
9. M 0.0173 0.0176 0.0023 58 
10. M 0.0114 0.0123 0.0028 20 
Group mean 0.0116 0.0149 0.0006 545 
Thyroiditis (T) 
1. F 0.0075 0.0102 0.0013 65 
2. F 0.0148 0.0162 0.0022 52 
3. F 0.0179 0.0174 0.0025 48 
Group mean 0.0128 0.0151 0.0012 165 
Benign adenomas (A) 
1. F 0.0154 0.0191 0.0028 47 
2. F 0.0105 0.0127 0.0014 80 
3. F 0.0141 0.0123 0.0013 97 
4. F 0.0110 0.0136 0.0017 65 
5. F 0.0155 0.0171 0.0014 149 
6. M 0.0151 0.0152 0 .0017 82 
Group mean 0.0138 0.0152 0.0007 520 
Differentiated carcinomas (D) 
1. F 0.0099 0.0136 0 .0019 49 
2. F 0.0112 0.0118 0.0012 98 24 
3. F 0.0106 0.0145 0 .0015 98 
4. F 0.0124 0.0155 0.0013 149 
5. F 0.0175 0.0171 0.0017 99 
6. F 0.0232 0.0178 0.0027 43 
7. M 0.0311 0.0187 0.0023 67 
8. M 0.0245 0.0139 0.0020 50 132 
Group mean 0.0161 0.0167 0.0007 653 
Undifferentiated tumors (UD) 
1. F 0.0099 0.0106 0.0015 51 2 
2. F 0.0275 0.0185 0.0018 101 12 
3. F 0.0361 0.0426 0.0029 223 0 
4. M 0.0212 0.0187 0.0011 285 1 
5. M 0.0157 0.0166 0.0020 69 48 
Group mean 0.0253 0.0290 0.0011 729 
Notes: F = female, M = male; S.D . = standard deviation; S.E.M . = standard error of the mean; PS = postoperative 
survival in months (if no figure is given, the patient is alive at the moment of the closure of this manuscript) . Group 
means are calculated from the total cell pool of the group , i.e., not as the average of the individual means. 
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Table 2. Average P/B values of phosphorus in the nuclei of intact thyroid, thyroiditis, and thyroid tumor cells of 
various levels of malignancy (n = number of measured cells) . 
!dent. Sex P/B ± S.D . ± S.E.M. n PS 
Control thyroid tissue (C) 
1. F 0.9827 0.1910 0.0171 125 
2. F 0.8017 0.1789 0.0231 60 
3. F 0.8577 0. 1862 0.0302 38 
4. F 0.9219 0.1270 0.0232 30 
5. F 0.8407 0.1294 0.0167 60 
6. F 0.9426 0.1427 0.0159 81 
7. F 0.8318 0.1627 0.0257 40 
8. F 0.9275 0.1916 0.0333 33 
9. M 1.0130 0.1398 0.0184 58 
10. M 0.9160 0.1871 0.0419 20 
Group mean 0.9155 0.1792 0.0077 545 
Thyroiditis (T) 
1. F 0 .8594 0. 1836 0.0227 65 
2. F 0.8168 0 .0780 0.0108 52 
3. F 0.8900 0.1393 0.0201 48 
Group mean 0.8549 0.1464 0.0114 165 
Benign adenomas (A) 
1. F 0.9854 0.2271 0.0331 47 
2. F 0.9332 0.2265 0.0253 80 
3. F 0.9611 0. 1589 0.0161 97 
4. F 0.8722 0.1310 0.0163 65 
5. F 1.0377 0.2004 0.0164 149 
6. M 0.8369 0.1116 0.0123 82 
Group mean 0.9502 0.1943 0.0085 520 
Differentiated carcinomas (D) 
1. F 0.7918 0 .1577 0.0225 49 
2. F 0.7132 0.0924 0.0093 98 24 
3. F 0.9146 0.1195 0.0121 98 
4. F 0.9633 0.1945 0.0159 149 
5. F 1.0095 0.2186 0.0220 99 
6. F 0.9277 0.2325 0.0355 43 
7. M 1.0234 0.1798 0.0220 67 
8. M 0.9788 0.1313 0.0186 50 132 
Group mean 0.9176 0.1993 0.0078 653 
Undifferentiated tumors (UD) 
1. F 0.7269 0.1044 0.0146 51 2 
2. F 0.9625 0.1461 0.0145 101 12 
3. F 0.7692 0.0989 0.0066 223 0 
4. M 0.7647 0.1462 0.0087 285 1 
5. M 1.0152 0.1238 0.0149 69 48 
Group mean 0.8145 0.1595 0.0059 729 
Notes: F = female, M = male; S.D. = standard deviation; S.E .M. = standard error of the mean; PS = postoperative 
survival in months (if no figure is given, the patient is alive at the moment of the closure of this manuscript). Group 
means are calculated from the total cell pool of the group, i.e., not as the average of the individual means. 
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Table 3. ANOV A table of the nested (hierarchical) analysis of variance for the relative magnesium and phosphorus 
contents of cell nuclei on the 5 groups and 32 subgroups described in Tables 1 and 2. 
Source of variation dF ss MS 
Magnesium 
Among groups 4 0.075405 0.018851 4.38 
Fo.01(4,24) = 4.18 
Among subgroups 25+ 0.091185 0.004305 11.24 
Fo.001(4,oo) = 2.13 
Within subgroups 2580 0.988205 0.000383 
-Total --------------------2609 _______ 1.154796 ____________ 0 .000442 ----------------- - - -
Phosphorus 
Among groups 4 7.091539 1.772885 1.94 
Fo.I0(4,26) = 2.17 
Among subgroups 26++ 19.026850 0.915229 35.81 
Fo.001(24,oo) = 2.13 
Within subgroups 2580 65.938440 0 .025558 
-Total----------- 2610 92.056830 0.035257 
Notes: dF = degree of freedom; SS = sum of squares; MS = mean square ; F(calc) = calculated F-value; F(crit) = 
conservative critical value employed to avoid interpolation (for the probability and degrees of freedom indicated); dF+ 
and dF+ + are rounded from the calculated values of 25 .5699 and 26 .5385, respectively; significance can be established 
at the level of indicated probabilities where F(calc) > F (crit)· 
The design of the statistical evaluation was a two-
level nested ANOV A variance analysis with unequal sa-
mple sizes {see for details : Chapter 10 (pp. 294-301) of 
Sokal and Rohlf , 1981} performed for Mg and P , as 
follows: 
(1) The histopathological diagnoses of the tissue 
samples were considered as the main groups (C, T , A, 
D and UD). 
(2) The cell nuclei measured within a sample of a 
given diagnosis deriving from the same individual, were 
taken as the subgroups (altogether 32). In each sub-
group, various numbers of cell nuclei were measured, 
totaling 2611 (Tables 1 and 2). 
The computerized statistical analysis gave the nested 
ANOV A results summarized in Table 3. Tests of signif-
icance were completely justified in terms of the mathe-
matical requirements (Sokal and Rohlf, 1981, p. 298). 
It is evident from the F-values shown in Table 3 
that the intranuclear Mg contents of the 5 thyroid tissue 
groups differ significantly from each other at a probabil-
ity level of p < 0.01, since the obtained F = 4.38 is 
larger than the critical value F0_01c4,25) = 4.18 (Sokal 
and Rohlf, 1981). At the same time, the differences in 
the P-contents of the same groups are statistically not 
significant (p > 0.10). 
Table 3 also demonstrates that the variances between 
subgroups for both Mg and P contents are significantly 
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larger than the intra-subgroup mean square (MS) values , 
i .e. , the individual scatter of these data is considerable 
between various persons. In other words, this means 
that we have to measure cells from several control 
people and several from each diagnostic groups , in order 
to get a realistic view of the situation . It is important to 
stress that the among group differences of the Mg con-
tents remained statistically significant above the individ-
ual variations of this parameter, whereas in case of P 
contents, the among group differences disappeared when 
a sufficient number of individuals were involved in the 
data collection (Table 3). 
The F-values obtained for "among subgroups" were 
larger than those of the "among groups" (Table 3). This 
fact suggest that pooling together all the cell nuclei with-
in the same group cannot result in any misleading, or 
"false" significance values. On the contrary, pooling to-
gether all data in the same group can offer a more real-
istic judgement of observed differences among groups. 
Table 4 expresses our group averages in relative 
terms, taking the average of control cases as 100 % ± 
standard error of the mean (S.E.M .), and expressing all 
other group averages in relation to this level. It is in-
teresting to note that the average increase of Mg con-
tents correlates with the known malignancy of the thy-
roid tumors: This increase is moderate (19.8%) in the 
benign adenomas, larger (39.3 %) in the differentiated 
Internuclear Mg and P in human thyroid tumors 
Table 4. Relative magnesium and phosphorus contents in the nuclei of intact and tumorous thyroid cells. 
Cell type (symbol) Relative Mg content ± S.E .M . Number of cell Significance p < 
(%) nuclei 
Magnesium: 
Control (C) 100.00 5.51 545 
Thyroiditis (T) 111.12 10.20 165 (C/T) N.S . 
Adenoma (A) 119.81 5.76 520 (C/A) 0.01 
Differentiated carcinoma (D) 139.32 5.67 653 (C/D) 0.001 
(D/UD) 0.001 
Undifferentiated tumors 219.01 9.29 729 (C/UD) 0 .001 
(UD) 
(A/UD) 0.001 
Phosphorus: 
Control (C) 100.00 0.84 545 
Thyroiditis (T) 93.38 1.25 165 (C/T) 0 .01 
Adenoma (A) 103.79 0 .93 520 (C/A) 0 .01 
Differentiated carcinoma (D) 100.23 0.85 653 (C/D) N .S. 
(D/UD) 0.001 
Undifferentiated tumors 88.97 0 .65 729 (C/UD) 0 .001 
(UD) 
(A/UD) 0.001 
Notes : N.S. = not significant; comparisons are indicated by the relevant group symbols in the last column, performed 
by the Students t-test. 
------------- -------------------------------------------------------------------------------
carcinomas, and extremely large (119 % ) in the undiffer -
entiated tumors . Comparisons to the C group by the 
Student's t test are highly significant for Mg contents in 
any pair of groups , except the C/T comparison (Table 
4). 
The malignancy of the tumors investigated has been 
confirmed also by the clinical course of the disease: Ta-
bles 1 and 2 give the postoperative survival times of the 
patients . Where no figure is indicated, the patient is still 
alive at the closure of this manuscript. In Group D , we 
had two deaths out of 8, with a relatively long postoper -
ative survival, whereas from the Group UD nobody is 
actually surviving. 
As regards the P-contents, no clear correlation can 
be seen with the increasing malignancy of the tumors. 
As a matter of fact, although some group-comparisons 
proved to be statistically significant by the Student ' s 
t-test (Table 4), the tendencies were contradictory: a 
decrease was observed in the T and UD groups, no 
change was seen in the D group and an increase was 
recorded in the A group (Table 4). 
It should be noted that the actual cell counts given 
in Tables 1 and 2 differ from those published in our 
previous papers (Lukacs et al., 1983; Zs.-Nagy et al., 
1983). The explanation for these differences is twofold: 
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(a) In the case of the controls, the benign adenomas and 
differentiated carcinomas , the measurements were con-
tinued after the communications mentioned had been sent 
to press, thus , here we can present a larger cell count. 
(b) In one case of undifferentiated carcinoma, the histo-
pathological diagnosis had to be revised on the basis of 
later examinations. This tumor, first diagnosed as an 
anaplastic carcinoma, was later reclassified as medullary 
carcinoma. This revision had to be carried out since in 
the course of the clinical follow-up, an elevated calci-
tonin serum level was found in the patient, which raised 
suspicion of medullary carcinoma. This suspicion was 
later verified by the positive result of the Congo-red test 
performed on the original operative material, which 
suggested the presence of amyloid . This is why the Mg 
concentrations found in this material are also included in 
the group of differentiated carcinomas. 
Attention should be called to another fact. In our 
original studies, we established the parameters of mea-
surements suitable for monovalent electrolytes (Na, K 
and Cl), the intracellular concentration of which is high-
er than that of Mg. An analysis time of 40 seconds was 
quite sufficient even for Na, however, this measuring 
time cannot be regarded as optimal for Mg. The result 
of this situation was that in certain cell nuclei the X-ray 
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spectra gave a zero value for the Mg peak, when the 
Mg-impulses, relatively smaller in number, did not sig-
nificantly exceed the background intensity. The values 
presented now also contain these O measurements, al-
though we can be sure that Mg is contained in all nuclei, 
so the O value can only be considered an error in the 
measurement. However, since to arbitrarily neglect 
these O values would have resulted in an upward correc-
tion of the P/B ratios, we did not omit them. This fact 
does not impair the comparability of the measured re-
sults, it only causes an increase of the standard deviation 
(S.D.) . As a matter of fact, the S.D . values for Mg 
may be larger than the individual or group averages , as 
shown in Tables 1 and 2. 
Discussion 
It is generally known that in the sera of tumor pa-
tients lower Mg levels are found than in those of healthy 
persons (Anghileri et al., 1981; Collery et al., 1981; 
Durlach, 1985; Holtmeier, 1988). Our own observa-
tions with thyroid tumor patients are similar, as we 
found in them an average of 1.37 ± 0.15 (S.D.) mEq/1 
Mg, whereas in sera of healthy individuals the mean 
reached 1.89 ± 0.11 mEq/l (Dray et al. , 1978). It was 
the generally encountered hypomagnesemia that sug-
gested the possibility of an attempt at treatment of tumor 
patients with Mg supplementation (Blondell, 1980). 
However , it has so far not been proven that the growth 
of tumors can actually be diminished by Mg administra -
tion (Holtmeier , 1988); in fact, some data suggest that 
Mg depletion has a regressional effect on the growth of 
the tumor in terminal-stage patients (Parsons et al., 
1974), therefore, the question is worth serious consider-
ation. On the other hand, according to Durlach et al. 
(1986), Mg admini stration for several lymphoreticular 
tumors appears to have an anticancer effect, whereas in 
solid tumors, very often, Mg rather stimulates tumor 
growth . On this basis, these latter authors recommend 
Mg therapy only for the previously mentioned types of 
tumors as adjuvant treatment , and in the solid tumors , 
they consider it as contraindicated. 
The increase of the intranuclear Mg concentration 
observed by us in positive correlation with the increasing 
malignancy of the thyroid tumors seems to support the 
findings reviewed by Cameron and Smith (1989a) , ac-
cording to which the more rapidly dividing cells contain 
more intracellular Mg. The non-parallel changes ob-
served in the P contents suggest that one can reject the 
hypothesis according to which the Mg-content would 
have increased simply because of a greater P (i.e., phos-
phate ion) content. On the other hand, our data are also 
in agreement with those of Durlach et al . (1986), who 
described a mitogenic effect of increased Mg content in 
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the cell nucleus. In this respect, the onset of hypomag -
nesemia observed in the presence of thyroid tumors can 
probably be interpreted so that the changes in the perme-
ability conditions of the cell membrane accompanying 
( or perhaps causing) mitogenic activity induce the tumor 
tissue to increase considerably its Mg uptake, and the se-
rum-level regulating mechanisms are unable to compen-
sate for this process. The consequent hypomagnesemia, 
very naturally, may involve unpleasant symptoms such 
as muscular weakness, tremor, and tetanic spasms. 
(Wester and Dyckner, 1982; Berkelhammer and Bear, 
1985; Holtmeier, 1988). The treatment of these symp-
toms is possible and Mg-supplementation may be recom-
mended. Nevertheless, we must not forget that exces-
sive administration of Mg may further increase the Mg 
uptake of the existing tumor cells , and may promote the 
progression of the tumor. 
Another aspect of hypomagnesemia is the problem 
that certain antitumor drugs, such as cisplatin and adria-
mycin, while they inhibit tumor cell growth, cause hypo-
magnesemia, too (Durlach et al., 1986; Araszkiewicz et 
al., 1987). 
All these data and results suggest that knowledge of 
the Mg level in the serum alone is not enough to judge 
the metabolic changes of this element in tumor patients. 
The method used by us for the measurement of intracel-
lular Mg content is not a routine technique, however, 
since it is the only possibility of gaining such data, it 
may be necessary in places where clinical practice and 
research capacity are close to each other. The aim to 
deplete high intracellular Mg content by certain pharma-
cological interference does not seem impossible, and by 
this means, we can hinder tumor growth in a target-
oriented way. There have been animal experiments to 
this effect: e.g., the growth of C3HBA breast adeno-
carcinoma has been considerably inhibited by the oral 
administration of gallium-chloride, which resulted in a 
significant reduction both in the weight of the tumor and 
the Mg content of the tumorous tissue, whereas the Mg 
content of the kidneys remained unchanged (Collery et 
al., 1986). We do not want to exaggerate the signifi-
cance of the results so far achieved, but wish to empha-
size the importance of the extension of these investiga-
tions in this direction, all the more so as surgical treat-
ment for rapidly growing, highly malignant tumors has 
so far hardly been successful , thus one cannot overesti-
mate the importance of a target-oriented, successful 
chemotherapeutical procedure. 
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Editor's Note: All of the reviewer's concerns were 
appropriately addressed by text changes, hence there is 
no Discussion with Reviewers. 
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